Volunteer in our research studies

A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Patients with Meibomian Gland Dysfunction (MGD)

• Adult aged 18 years or over
• Signs and symptoms of dry eye within the last 3 months
• Wiling to discontinue other treatments for dry eye and MGD for at least 2 weeks prior to the first visit and for the duration of the study  
• Willing to provide written informed consent and likely to complete the entire course of study according to instructions
• Not pregnant or breastfeeding

The role of the microbiome in dry eye

• Are aged over 18 years
• Have not worn contact lenses in the past 3 months
• [Meibomian gland dysfunction group] Have been diagnosed with mild to moderate meibomian gland dysfunction, either with or without lacrimal gland dysfunction
• [Healthy group] Do not have meibomian gland dysfunction or dry eye
• Have not had any eye trauma or eye surgery (including previous cataract or corneal refractive surgery)
• Must not be using any systematic or topical antibiotic, anti-inflammatory, immunosuppressive medication, over the counter drops containing preservatives and also topical galucoma medication in the past 3 months

Tear film telomerase in dry eye disease

• Are aged over 18 years.
• Have dry eyes.
• Not a contact lens wearer
• Not pregnant or lacting
• Not taking eye medications or corticosteroids.

The impact of probiotics and prebiotics on dry eye disease  

• Are aged over 18 years
• Have reported dry eye signs and symptoms within the past three months
• Do not have any systemic or auto-immune diseases
• No previous probiotic or fermented product intake in the last three months
• Are willing to provide written informed consent and likely to comply with the consuming probiotic product and clinical trial visit schedule
• Contact Maria Markoulli